For instance, TF acted as an angiogenesis-specific receptor in angiogenic VECs of the age-related macular degeneration (AMD) (29) pathological neovasculature of endometriosis (30) and solid cancers, including melanoma (11), lung cancer (31–33) as well as breast cancer (34–37). Here, TF is linked to age-related macular degeneration.